Centiva Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.41M Buy
150,288
+114,037
+315% +$6.19M 0.06% 232
2026
Q1
$2.27M Buy
+36,251
New +$2.9M 0.02% 401
2025
Q3
Sell
-13,689
Closed -$1.47M 1164
2025
Q2
$1.47M Sell
13,689
-2,343
-15% -$237K 0.02% 452
2025
Q1
$1.62M Buy
16,032
+7,871
+96% +$793K 0.05% 253
2024
Q4
$729K Sell
8,161
-6,843
-46% -$602K 0.02% 636
2024
Q3
$1.26M Sell
15,004
-4,536
-23% -$358K 0.02% 718
2024
Q2
$1.5M Buy
+19,540
New +$1.43M 0.03% 561
2024
Q1
Sell
-5,773
Closed -$371K 1797
2023
Q4
$334K Buy
5,773
+3,714
+180% +$198K 0.01% 1158
2023
Q3
$109K Sell
2,059
-28,726
-93% -$1.51M ﹤0.01% 1507
2023
Q2
$1.67M Buy
30,785
+28,114
+1,053% +$1.47M 0.04% 435
2023
Q1
$134K Sell
2,671
-16,039
-86% -$756K ﹤0.01% 1304
2022
Q4
$866K Buy
+18,710
New +$810K 0.02% 611
2022
Q3
Sell
-10,585
Closed -$395K 1510
2022
Q2
$395K Buy
+10,585
New +$431K 0.01% 1029
2021
Q3
Sell
-38,999
Closed -$1.67M 1295
2021
Q2
$1.67M Buy
+38,999
New +$1.64M 0.04% 386
2019
Q4
Sell
-53,995
Closed -$2.2M 808
2019
Q3
$2.2M Buy
+53,995
New +$2.29M 0.13% 158

Other funds holding BSX

Centiva Capital's BSX Position: Q2 2026 in Review

Centiva Capital increased its Boston Scientific (BSX) stake by 315% in Q2 2026, buying an estimated $6.19M and bringing the position to 150,288 shares worth $6.41M. The position accounts for 0.06% of the portfolio, ranked #232.

Centiva Capital first reported a position in BSX in Q3 2019 and has held it in 15 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Centiva Capital held 150,288 shares of Boston Scientific worth $6.41M as of Q2 2026.
  • Centiva Capital bought 114,037 Boston Scientific shares in Q2 2026, an estimated $6.19M.
  • Boston Scientific made up 0.06% of Centiva Capital's portfolio in Q2 2026, its #232 holding.
  • Centiva Capital first reported a position in Boston Scientific in Q3 2019 and has held it in 15 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.